BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25376910)

  • 1. Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.
    Jiang Y; Simon S; Mayo MS; Gajewski BJ
    Stat Med; 2015 Feb; 34(4):613-29. PubMed ID: 25376910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian modeling and prediction of accrual in multi-regional clinical trials.
    Deng Y; Zhang X; Long Q
    Stat Methods Med Res; 2017 Apr; 26(2):752-765. PubMed ID: 25367100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
    Gajewski BJ; Berry SM; Quintana M; Pasnoor M; Dimachkie M; Herbelin L; Barohn R
    Stat Med; 2015 Mar; 34(7):1134-49. PubMed ID: 25640114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of informative priors skeptical of large treatment effects in clinical trials: A simulation study.
    Pedroza C; Han W; Truong VTT; Green C; Tyson JE
    Stat Methods Med Res; 2018 Jan; 27(1):79-96. PubMed ID: 26668090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.
    Liu J; Wick J; Jiang Y; Mayo M; Gajewski B
    Pharm Stat; 2020 Sep; 19(5):692-709. PubMed ID: 32319194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Method for Constructing Informative Priors for Bayesian Modeling of Occupational Hygiene Data.
    Quick H; Huynh T; Ramachandran G
    Ann Work Expo Health; 2017 Jan; 61(1):67-75. PubMed ID: 28395307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
    Liu J; Wick JA; Mudaranthakam DP; Jiang Y; Mayo MS; Gajewski BJ
    Clin Trials; 2019 Dec; 16(6):657-664. PubMed ID: 31451012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian approach to non-inferiority trials for normal means.
    Gamalo MA; Wu R; Tiwari RC
    Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian accrual prediction for interim review of clinical studies: open source R package and smartphone application.
    Jiang Y; Guarino P; Ma S; Simon S; Mayo MS; Raghavan R; Gajewski BJ
    Trials; 2016 Jul; 17(1):336. PubMed ID: 27449769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of ML, WLSMV, and Bayesian Methods for Multilevel Structural Equation Models in Small Samples: A Simulation Study.
    Holtmann J; Koch T; Lochner K; Eid M
    Multivariate Behav Res; 2016; 51(5):661-680. PubMed ID: 27594086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian sample size calculations in phase II clinical trials using informative conjugate priors.
    Mayo MS; Gajewski BJ
    Control Clin Trials; 2004 Apr; 25(2):157-67. PubMed ID: 15020034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of the β-Substitution Method and a Bayesian Method for Analyzing Left-Censored Data.
    Huynh T; Quick H; Ramachandran G; Banerjee S; Stenzel M; Sandler DP; Engel LS; Kwok RK; Blair A; Stewart PA
    Ann Occup Hyg; 2016 Jan; 60(1):56-73. PubMed ID: 26209598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power prior: theory and applications.
    Ibrahim JG; Chen MH; Gwon Y; Chen F
    Stat Med; 2015 Dec; 34(28):3724-49. PubMed ID: 26346180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction models for clustered data with informative priors for the random effects: a simulation study.
    Ni H; Groenwold RHH; Nielen M; Klugkist I
    BMC Med Res Methodol; 2018 Aug; 18(1):83. PubMed ID: 30081875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic modeling and prediction for accrual in clinical trials.
    Zhang X; Long Q
    Stat Med; 2010 Mar; 29(6):649-58. PubMed ID: 20082363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-parametric Bayesian regression for subgroup analysis in clinical trials.
    Gamalo-Siebers M; Tiwari R
    J Biopharm Stat; 2019; 29(6):1024-1042. PubMed ID: 30747568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.